Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial.
Belin L, Kamal M, Mauborgne C, Plancher C, Mulot F, Delord JP, Gonçalves A, Gavoille C, Dubot C, Isambert N, Campone M, Trédan O, Ricci F, Alt M, Loirat D, Sablin MP, Paoletti X, Servois V, Le Tourneau C.
Belin L, et al. Among authors: plancher c.
Ann Oncol. 2017 Mar 1;28(3):590-596. doi: 10.1093/annonc/mdw666.
Ann Oncol. 2017.
PMID: 27993804
Free article.
Clinical Trial.